J7182 is the authoritative medical code for Injection, factor viii, (antihemophilic factor, recombinant), novoeight, per iu. This classification is used in medical billing and clinical recording to specify the clinical criteria for injection, factor viii, (antihemophilic factor, recombinant), novoeight, per iu (HCPCS Level II J7182), ensuring healthcare documentation aligns with 2026 federal coding standards.
Billing Status: Processed within HCPCS Level II standards. CMS regulatory guidelines apply.
Official Registry Overview & Definition
Injection, factor viii, (antihemophilic factor, recombinant), novoeight, per iu is a HCPCS Level II code J7182 for a Medicare-covered supply, service, or procedure. Short description: Factor viii recomb novoeight.
Nearest Codes in This Family
Official HCPCS Level II classifications closest to J7182 in its code family, with their registry titles.
- J7100 — Infusion, dextran 40, 500 ml
- J7110 — Infusion, dextran 75, 500 ml
- J7120 — Ringers lactate infusion, up to 1000 cc
- J7121 — 5% dextrose in lactated ringers infusion, up to 1000 cc
- J7131 — Hypertonic saline solution, 1 ml
- J7165 — Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
- J7168 — Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
- J7169 — Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
- J7170 — Injection, emicizumab-kxwh, 0.5 mg
- J7171 — Injection, adamts13, recombinant-krhn, 10 iu
View all 36 codes in the J7100 family